KLRA Kailera Therapeutics, Inc.
Fundamentals / CIK 0002096997 / USDKailera Therapeutics, Inc. reported $1.08B in total assets through September 30, 2026 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open KLRA in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2026-- Sep 30, 2026
-
Operating Income FY 2026-- Operating profit
-
Net Income FY 2026-- GAAP bottom line
-
Diluted EPS FY 2026-- Split-adjusted
-
Free Cash Flow FY 2026-- Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$901.5M Total debt: $9.97M
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Research & Development | $84.67M | $101.1M | $70.87M | $26.99M | $19.52M | $10.13M |
| Total Operating Expenses | $106.3M | $121.4M | $84.66M | $40.11M | $30.65M | $20.46M |
| Operating Income | -$106.3M | -$121.4M | -$84.66M | -$40.11M | -$30.65M | -$20.46M |
| EBITDA | -$106.2M | -$121.3M | -$84.56M | -$40.05M | -$30.59M | -$20.39M |
| Net Income | -$95.67M | -$111.3M | -$78.86M | -$39.62M | -$28.95M | -$17.98M |
| Basic EPS | -$0.74 | -$1.09 | -$3,650.00 | -$39,623.00 | -$28,947.00 | -$17,983.00 |
| Diluted EPS | -$0.74 | -$1.09 | -$3,650.00 | -$39,623.00 | -$28,947.00 | -$17,983.00 |
| Basic Shares Outstanding | 129.7M | 102.2M | 21.6K | 1 | 1 | 1 |
| Diluted Shares Outstanding | 129.7M | 102.2M | 21.6K | 1 | 1 | 1 |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
|---|---|---|---|---|
| Cash & Cash Equivalents | $106.5M | $130.3M | $111.8M | $160.3M |
| Short-Term Investments | $794.9M | $786.4M | $407.3M | $385.8M |
| Cash & Short-Term Investments | $1.04B | $1.17B | $581.9M | $546.1M |
| Other Current Assets | $4.89M | $395K | $360K | $4.22M |
| Total Current Assets | $919.8M | $929.2M | $530.3M | $557.5M |
| Property, Plant & Equipment, Net | $1.65M | $1.75M | $1.85M | $1.96M |
| Long-Term Investments | $136.2M | $255.1M | $62.75M | $106.7M |
| Other Non-Current Assets | $63K | $90K | $5.59M | $2.72M |
| Total Non-Current Assets | $162.4M | $282.2M | $94.44M | $134.8M |
| Total Assets | $1.08B | $1.21B | $624.8M | $692.3M |
| Accounts Payable | $9.43M | $19.20M | $7.09M | $7.53M |
| Total Current Liabilities | $42.12M | $83.65M | $54.84M | $46.41M |
| Other Non-Current Liabilities | $67K | $135K | $201K | $270K |
| Total Non-Current Liabilities | $8.95M | $9.30M | $9.64M | $9.98M |
| Total Liabilities | $51.06M | $92.95M | $64.48M | $56.39M |
| Total Debt (incl. Leases) | $9.97M | $10.22M | $10.47M | $10.75M |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$654.5M | -$558.8M | -$447.5M | -$368.7M |
| Accumulated Other Comp. Income | -$3.74M | -$1.79M | -$532K | $229K |
| Total Stockholders' Equity | $1.03B | $1.12B | -$432.1M | -$356.5M |
| Total Equity | $1.03B | $1.12B | -$432.1M | -$356.5M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Net Income | -$95.67M | -$111.3M | -$78.86M | -$39.62M | -$28.95M | -$17.98M |
| Depreciation & Amortization | $101K | $101K | $101K | $63K | $62K | $63K |
| Stock-Based Compensation | $9.92M | $8.34M | $3.94M | $4.27M | $1.63M | $1.52M |
| Change in Payables | -$9.77M | $12.34M | -$495K | $154K | -$837K | $645K |
| Operating Cash Flow | -$133.7M | -$77.53M | -$68.31M | -$29.70M | -$26.23M | -$18.20M |
| Purchases of Investments | -$37.06M | -$689.8M | -$48.45M | -$42.28M | -$82.17M | -$54.44M |
| Investing Cash Flow | $110.8M | -$571.0M | $22.85M | $26.48M | -$74.17M | -$54.44M |
| Financing Cash Flow | -$922K | $667.0M | -$2.98M | -$243K | $100.0M | $0 |
| Net Change in Cash | -$23.76M | $18.48M | -$48.44M | -$3.46M | -$403K | -$72.64M |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Current Ratio | 21.84x | 11.11x | 9.67x | -- | -- | -- |
| Quick Ratio | 24.64x | 14.01x | 10.61x | -- | -- | -- |
| Debt to Equity | 0.01x | 0.01x | -- | -- | -- | -- |